These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibition of Candida albicans adhesiveness to human buccal and vaginal cells by sub-inhibitory concentrations of rilopirox. Braga PC, Dal Sasso M, Maci S, Piatti G, Dannhorn DR, Bohn M. Arzneimittelforschung; 1995 Jan; 45(1):84-7. PubMed ID: 7893277 [Abstract] [Full Text] [Related]
5. In vitro antifungal sensitivity of fluconazole, clotrimazole and nystatin against vaginal candidiasis in females of childbearing age. Khan F, Baqai R. J Ayub Med Coll Abbottabad; 2010 Jan; 22(4):197-200. PubMed ID: 22455297 [Abstract] [Full Text] [Related]
16. In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis. Fan SR, Liu XP. Mycoses; 2011 Nov; 54(6):501-5. PubMed ID: 20406393 [Abstract] [Full Text] [Related]
17. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use]. Saporiti AM, Gómez D, Levalle S, Galeano M, Davel G, Vivot W, Rodero L. Rev Argent Microbiol; 2001 Nov; 33(4):217-22. PubMed ID: 11833253 [Abstract] [Full Text] [Related]
18. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC. Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [Abstract] [Full Text] [Related]